Myomo, Inc. (MYO)

Market Cap	27.77M -81.9%
Revenue (ttm)	40.93M +25.7%
Net Income	-15.57M
EPS	-0.37
Shares Out	38.51M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	225,692
Open	0.7790
Previous Close	0.7398
Day's Range	0.7101 - 0.7790
52-Week Range	0.6260 - 5.6200
Beta	1.13
Analysts	Strong Buy
Price Target	7.67 (+963.65%)
Earnings Date	Mar 9, 2026

About MYO

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the bra...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 12, 2017
• Employees: 195
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: MYO
• Website: https://myomo.com

Financial Performance

In 2025, Myomo's revenue was $40.93 million, an increase of 25.73% compared to the previous year's $32.55 million. Losses were -$15.57 million, 151.9% more than in 2024.

Analyst Summary

According to 3 analysts, the average rating for MYO stock is "Strong Buy." The 12-month stock price target is $7.67, which is an increase of 963.65% from the latest price.

Price Target

$7.67

(963.65% upside)

Analyst Consensus: Strong Buy